A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Totus Medicines
Totus Medicines
Hoffmann-La Roche
Eli Lilly and Company
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Royal Marsden NHS Foundation Trust
Pfizer
American Society of Clinical Oncology
Hoffmann-La Roche
Eli Lilly and Company
Pfizer
Celcuity Inc
Forward Pharmaceuticals Co., Ltd.
Stemline Therapeutics, Inc.
Weill Medical College of Cornell University
Avenzo Therapeutics, Inc.
Northwestern University
Criterium, Inc.
Relay Therapeutics, Inc.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Lebanese University
National Taiwan University Hospital